Chloé Beate Steen
Chloé Beate Steen
Chloé Steen is a postdoctoral fellow at the Department of Cancer Immunology, Oslo University Hospital, and K.G. Jebsen Centre for B-cell Malignancies. She is a recipient of the American Association for Cancer Research lymphoma research fellowship, which she was awarded as a postdoc at Stanford University.
Steen holds a PhD in bioinformatics from the University of Oslo, and is working on computational approaches to characterize the tumor microenvironment in various types of cancers. Her goal is to develop computational tools for improved diagnosis and to guide precision medicine in cancer.
Position
Postdoctoral fellow at Department of Cancer Immunology (Myklebust group), Institute for Cancer Research, Oslo University Hospital
Selected publications
Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H. Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series. Blood Adv. 2020 May 12;4(9):1859-1866. doi: 10.1182/bloodadvances.2019001325
Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019 Jul;37(7):773-782. doi: 10.1038/s41587-019-0114-2.
Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M. A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy. Haematologica. 2019 Oct;104(10):e460-e464. doi: 10.3324/haematol.2018.209080.